Search

Your search keyword '"López-Quintero, Andres"' showing total 14 results
Start Over Author "López-Quintero, Andres"
14 results on '"López-Quintero, Andres"'

1. STAT4 Gene Variant rs7574865 Is Associated with Rheumatoid Arthritis Activity and Anti-CCP Levels in the Western but Not in the Southern Population of Mexico

Author

Bravo-Villagra, Karla Mayela, primary, Muñoz-Valle, José Francisco, additional, Baños-Hernández, Christian Johana, additional, Cerpa-Cruz, Sergio, additional, Navarro-Zarza, José Eduardo, additional, Parra-Rojas, Isela, additional, Aguilar-Velázquez, José Alonso, additional, García-Arellano, Samuel, additional, and López-Quintero, Andres, additional

Published
2024
Full Text
View/download PDF

4. Effect of Human Adenovirus 36 on Response to Metformin Monotherapy in Obese Mexican Patients with Type 2 Diabetes: A Prospective Cohort Study

Author

Tapia-Rivera, José Carlos, primary, Mendoza-Jaramillo, Héctor Eduardo, additional, González-Villaseñor, Christian Octavio, additional, Ramirez-Flores, Mario, additional, Aguilar-Velazquez, José Alonso, additional, López-Quintero, Andres, additional, Pérez-Guerrero, Edsaúl Emilio, additional, Vargas-Rodriguez, María de los Ángeles, additional, Gutiérrez-Hurtado, Itzae Adonai, additional, and Martínez-López, Erika, additional

Published
2023
Full Text
View/download PDF

5. Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy.

Author

Torres-Carrillo, Norma, Martínez-López, Erika, Torres-Carrillo, Nora Magdalena, López-Quintero, Andres, Moreno-Ortiz, José Miguel, González-Mercado, Anahí, and Gutiérrez-Hurtado, Itzae Adonai

Subjects
DRUG therapy, PATHOGENIC microorganisms, DRUG toxicity, DRUG metabolism, DRUG administration
Abstract

Microorganisms have a close relationship with humans, whether it is commensal, symbiotic, or pathogenic. Recently, it has been documented that microorganisms may influence the response to drug therapy. Pharmacomicrobiomics is an emerging field that focuses on the study of how variations in the microbiome affect the disposition, action, and toxicity of drugs. Two additional sciences have been added to complement pharmacomicrobiomics, namely toxicomicrobiomics, which explores how the microbiome influences drug metabolism and toxicity, and pharmacoecology, which refers to modifications in the microbiome as a result of drug administration. In this context, we introduce the concept of "drug-infection interaction" to describe the influence of pathogenic microorganisms on drug response. This review analyzes the current state of knowledge regarding the relevance of microorganisms in the host's response to drugs. It also highlights promising areas for future research and proposes the term "drug-infection interaction" as an extension of pharmacomicrobiomics. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

8. Estructura, señalización y regulación de la adiponectina en relación con la sensibilidad a la insulina y diabetes gestacional: Hallazgos clínicos y genéticos

Author

López-Quintero, Alba Esthela, primary, Cotero-de la Torre, Itzel Irazú, additional, Bravo-Villagra, Karla Mayela, additional, Herrera-Salazar, Adrián, additional, Picos-Cárdenas, Verónica Judith, additional, Morgan-Ortíz, Fred, additional, Trapero-Corona, Irak Mijail, additional, Muñoz-Valle, José Francisco, additional, and López-Quintero, Andres, additional

Published
2022
Full Text
View/download PDF

10. The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence

Author

Luna-Castillo, Karla Paulina, primary, Olivares-Ochoa, Xochitl Citlalli, additional, Hernández-Ruiz, Rocío Guadalupe, additional, Llamas-Covarrubias, Iris Monserrat, additional, Rodríguez-Reyes, Saraí Citlalic, additional, Betancourt-Núñez, Alejandra, additional, Vizmanos, Barbara, additional, Martínez-López, Erika, additional, Muñoz-Valle, José Francisco, additional, Márquez-Sandoval, Fabiola, additional, and López-Quintero, Andres, additional

Published
2022
Full Text
View/download PDF

12. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico

Author

Santoscoy‐Ascencio, Guillermo, primary, Baños‐Hernández, Christian Johana, additional, Navarro‐Zarza, José Eduardo, additional, Hernández‐Bello, Jorge, additional, Bucala, Richard, additional, López‐Quintero, Andres, additional, Valdés‐Alvarado, Emmanuel, additional, Parra‐Rojas, Isela, additional, Illades‐Aguiar, Berenice, additional, and Muñoz‐Valle, José Francisco, additional

Published
2019
Full Text
View/download PDF

14. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.

Author

Santoscoy‐Ascencio, Guillermo, Baños‐Hernández, Christian Johana, Navarro‐Zarza, José Eduardo, Hernández‐Bello, Jorge, Bucala, Richard, López‐Quintero, Andres, Valdés‐Alvarado, Emmanuel, Parra‐Rojas, Isela, Illades‐Aguiar, Berenice, and Muñoz‐Valle, José Francisco

Subjects
MACROPHAGE migration inhibitory factor, RHEUMATOID arthritis, DISEASE susceptibility
Abstract

Background: Macrophage migration inhibitory factor (MIF) is a cytokine capable of stimulating inflammatory cytokine and matrix metalloproteinase production from macrophages and synovial fibroblasts, which leads to persistent inflammation and bone degradation, two of the major pathological processes in rheumatoid arthritis (RA). The aim of this study was to evaluate the association of MIF promoter polymorphisms (−794CATT5‐8rs5844572 and −173G > C, rs755622), circulating MIF levels, and mRNA expression with RA susceptibility and disease activity. Methods: A case–control study was conducted in 200 RA patients and 200 control subjects (CS) from Southern Mexico. Genotyping was performed by conventional PCR and PCR‐RFLP methods. MIF mRNA expression was quantified by real‐time PCR and MIF serum levels were determined by an ELISA kit. Results: The 7,7 (−794CATT5‐8) and −173CC (−173G > C) genotypes were associated with higher disease activity in RA patients. MIF serum levels were increased, and MIF mRNA expression was reduced in RA patients as compared to CS. In addition, RA patients with moderate disease activity had higher MIF levels than those with low disease activity. The −794CATT5‐8 and −173G > C MIF polymorphisms were not associated with RA susceptibility. Conclusion: These results suggest an important role of MIF polymorphisms and MIF serum levels with disease activity in RA. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results